Evonik Prevents Hair Loss with Skin-identical Sphingolipid

Jan 8, 2014 | Contact Author | By: Katie Anderson
Your message has been sent.
(click to close)
Contact the Author
Save
This item has been saved to your library.
View My Library
(click to close)
Save to My Library
Title: Evonik Prevents Hair Loss with Skin-identical Sphingolipid
hair lossx androgenic alopoeciax scalpx folliclex androgenic alopeciax
  • Article
  • Keywords/Abstract

Keywords: hair loss | androgenic alopoecia | scalp | follicle | androgenic alopecia

Abstract: Evonik has launched a skin-identical sphingolipid that prevents hair loss by addressing scalp health, strengthening the hair follicle and rebalancing the lifecycle of hair.

Evonik has launched a skin-identical sphingolipid that prevents hair loss by addressing scalp health, strengthening the hair follicle and rebalancing the lifecycle of hair.

Sphingony (INCI: Sphinganine) has been shown in in vitro studies to balance the hair cycle by inhibition of 5-α-reductase, improving the scalp renewal capacity, stimulating formation of essential building blocks like proteins and ceramides and by improving scalp health by equalizing the microflora.

Extended in vivo studies have confirmed that the active significantly prevents hair loss by prolonging the anagen growth phase of hair and effectively improves hair quality and scalp health.

The new active will be presented at in-cosmetics 2014 in Hamburg, Germany.